Henning Priepke

Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors

Norbert Hauel, Herbert Nar, Henning Priepke et al. · Journal of Medicinal Chemistry · 2002 · 451 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Mechanism of Human Telomerase Inhibition by BIBR1532, a Synthetic, Non-nucleosidic Drug Candidate

Emanuelle Pascolo, Christian Wenz, Joachim Lingner et al. · Journal of Biological Chemistry · 2002 · 340 citations · Full text

Medicine, Cancer Biology, Medicinal Chemistry +13

In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate

Jean–Marie Stassen, Henning Priepke, Uwe J. Ries et al. · Thrombosis and Haemostasis · 2007 · 247 citations

Medicine, Medicinal Chemistry, Pharmacology +17

A Facile One‐Pot Synthesis of a Trisaccharide Unit from the Common Polysaccharide Antigen of Group B <i>Streptococci</i> Using Cyclohexane‐1, 2‐diacetal (CDA) Protected Rhamnosides

Steven V. Ley, Henning Priepke · Angewandte Chemie International Edition in English · 1994 · 139 citations

Life Sciences, Biochemistry, Microbiology +17

A New Strategy for Oligosaccharide Assembly Exploiting Cyclohexane‐1,2‐diacetal Methodology: An Efficient Synthesis of a High Mannose Type Nonasaccharide

Peter Grice, Steven V. Ley, Jörg Pietruszka et al. · Chemistry - A European Journal · 1997 · 93 citations

Life Sciences, Biochemistry, Molecular Biology +17